0 Commentaires
0 Parts
251 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Evènements
-
Blogs
-
Offres
-
Emplois
-
Courses
-
Connectez-vous pour aimer, partager et commenter!
-
Can AI Shorten Drug Development Timelines? The In-Silico Drug Discovery Market Thinks SoAccording to the latest report published by Data Bridge Market Research, the In-Silico Drug Discovery Market CAGR Value The global in-silico drug discovery market size was valued at USD 4,380.97 billion in 2024 and is expected to reach USD 12,150.59 billion by 2032, at a CAGR of 13.60% during the forecast period With the use of integrated approaches and latest technology for the...0 Commentaires 0 Parts 115 Vue 0 Aperçu
-
CMC Regulatory Strategy for Successful Drug DevelopmentA strong CMC regulatory strategy supports efficient product development and regulatory approval. Proper planning for chemistry, manufacturing, and controls ensures compliance, minimizes delays, and helps pharmaceutical companies bring safe, high-quality products to market successfully.0 Commentaires 0 Parts 177 Vue 0 Aperçu
-
CRO Services Market Expands as Pharmaceutical Firms Outsource Drug Development Activities" According to the latest report published by Data Bridge Market Research, the Contract Research Organization (CROs) Services Market CAGR Value The global contract research organization (CROs) services market size was valued at USD 61.70 billion in 2024 and is expected to reach USD 133.22 billion by 2032, at a CAGR of 10.10% during the forecast...0 Commentaires 0 Parts 25 Vue 0 Aperçu
-
Cyclooxygenase 1 Inhibitor Market Growth, Targeted Drug Development Trends and Forecast" According to the latest report published by Data Bridge Market Research, the Cyclooxygenase 1 Inhibitor Market The global Cyclooxygenase 1 Inhibitor market size was valued at USD 74.9 billion in 2024 and is expected to reach USD 128.69 billion by 2032, at a CAGR of 7.00% during the forecast period Cyclooxygenase 1 Inhibitor Market report contains...0 Commentaires 0 Parts 38 Vue 0 Aperçu
-
Diabetes Clinical Trials Market: Breakthrough Opportunities in Diabetes Drug DevelopmentIn an increasingly competitive and evolving business landscape, making informed decisions backed by reliable data has become essential for sustained growth and strategic planning. Market intelligence serves as a critical tool for businesses to respond effectively to shifting consumer demands, technological advancements, and emerging market trends. At Polaris Market Research, we are committed to...0 Commentaires 0 Parts 36 Vue 0 Aperçu
-
How Is Glycomics Market Advancing Biomedical Research and Drug Development?Glycomics/Glycobiology Market Summary: According to the latest report published by Data Bridge Market Research, the Glycomics/Glycobiology Market CAGR Value Global glycomics/glycobiology market size was valued at USD 24.43 billion in 2024 and is projected to reach USD 70.66 billion by 2032, with a CAGR of 14.2% during the forecast period of 2025 to 2032. This...0 Commentaires 0 Parts 183 Vue 0 Aperçu
-
Hyperacusis Drug Market Industry Outlook on Innovation, Investment and Market Development" According to the latest report published by Data Bridge Market Research, the Hyperacusis Drug Market The global hyperacusis drug market size was valued at USD 645.36 million in 2024 and is projected to reach USD 1,203.39 million by 2032, with a CAGR of 8.10% during the forecast period of 2025 to 2032. Hyperacusis Drug Market report, businesses can acquire details about market...0 Commentaires 0 Parts 119 Vue 0 Aperçu
-
Innovations in Drug Development Boost the Angiotensin Receptor Antagonists MarketThe global Angiotensin Receptor Antagonists Market is experiencing significant growth due to the rising prevalence of hypertension, cardiovascular diseases, chronic kidney disorders, and an aging population worldwide. Angiotensin receptor antagonists, commonly known as angiotensin II receptor blockers (ARBs), are widely prescribed medications that help lower blood pressure and reduce...0 Commentaires 0 Parts 161 Vue 0 Aperçu
-
Lurbinectedin Market Size, Share, Cancer Therapeutics Innovation & Oncology Drug Development Trends | Industry Forecast to 2029The Lurbinectedin Market has emerged as a notable niche within the oncology therapeutics landscape, driven by advancements in targeted cancer treatments and rising incidence of small cell lung cancer (SCLC) and select solid tumors. The lurbinectedin market is expected to witness market growth at a rate of 45.30% in the forecast period of 2022 to...0 Commentaires 0 Parts 369 Vue 0 Aperçu
-
Microsporidiosis Treatment Market Trends | Drug Development & Future Forecast" Microsporidiosis Treatment Market Summary: According to the latest report published by Data Bridge Market Research, the Microsporidiosis Treatment Market The global microsporidiosis treatment market size was valued at USD 285.50 billion in 2025 and is expected to reach USD 406.00 billion by 2033, at a CAGR of 4.50% during the forecast period This...0 Commentaires 0 Parts 204 Vue 0 Aperçu
-
Peramivir Market Trends: Advancements in Antiviral Drug Development and Intravenous Treatment ModalitiesThe global Peramivir Market is witnessing substantial growth owing to the increasing prevalence of influenza infections worldwide and the rising demand for effective antiviral therapeutics. According to market estimates, the Peramivir Market size is expected to reach US$ 335.48 million by 2034 from US$ 135.92 million in 2025, registering a CAGR of 10.56% during the forecast period from 2026 to...0 Commentaires 0 Parts 180 Vue 0 Aperçu
-
AI Clinical Trial Market Growing at 15% CAGR Through 2034According to a new report from Intel Market Research, the global AI Clinical Trial market was valued at USD 1.05 billion in 2025 and is projected to reach USD 3.45 billion by 2034, growing at a robust CAGR of 15 % during the forecast period (2025–2034). This expansion is driven by the escalating need for faster drug development, the rise of predictive analytics, and strong endorsement...0 Commentaires 0 Parts 310 Vue 0 Aperçu
-
Angina Pectoris Drugs Market Size and Revenue Forecast to 2033According to the latest report published by Data Bridge Market Research, the Angina Pectoris Drugs Market The global angina pectoris drugs market size was valued at USD 11.14 billion in 2025 and is expected to reach USD 17.09 billion by 2033, at a CAGR of 5.50% during the forecast period The universal Angina Pectoris Drugs Market report has...0 Commentaires 0 Parts 197 Vue 0 Aperçu
-
Breast Cancer Drugs Market Size and Revenue Forecast to 2030According to the latest report published by Data Bridge Market Research, the Breast Cancer Drugs Market Data Bridge Market Research analyzes that the global breast cancer drugs market is expected to reach USD 55,996.57 million by 2030 from USD 30,247.54 million in 2022, growing at a CAGR of 8.2% during the forecast period of 2023 to 2030. All the statistical data including...0 Commentaires 0 Parts 93 Vue 0 Aperçu
-
Castleman Disease Drug Market Growth, Pipeline Analysis & Global Forecast"Castleman Disease Drug Market According to the latest report published by Data Bridge Market Research, the Castleman Disease Drug Market The global Castleman Disease drug market was valued at USD 231.78 million in 2024 and is expected to reach USD 342.44 million by 2032 and is projected to grow at a CAGR of 5.0%, primarily driven by the...0 Commentaires 0 Parts 250 Vue 0 Aperçu
-
Circular RNA Therapeutics Market Size and Revenue Forecast to 2033According to the latest report published by Data Bridge Market Research, the Circular RNA Therapeutics Market The global Circular RNA Therapeutics market size was valued at USD 784 Million in 2025and is expected to reach USD 4188.13 Million by 2033, at a CAGR of 23.30% during the forecast period To impart a supreme quality to this persuasive Circular RNA...0 Commentaires 0 Parts 34 Vue 0 Aperçu
-
Circular RNA Therapeutics Market Size, Industry Trends, and Growth Forecast to 2033According to the latest report published by Data Bridge Market Research, the Circular RNA Therapeutics Market The global Circular RNA Therapeutics market size was valued at USD 784 Million in 2025 and is expected to reach USD 4188.13 Million by 2033, at a CAGR of 23.30% during the forecast period To impart a supreme quality to this persuasive Circular RNA...0 Commentaires 0 Parts 580 Vue 0 Aperçu
-
Cryptococcosis Treatment Market Size and Revenue Forecast to 2033According to the latest report published by Data Bridge Market Research, the Cryptococcosis Treatment Market The global cryptococcosis treatment market size was valued at USD 5.76 billion in 2025 and is expected to reach USD 10.04 billion by 2033, at a CAGR of 7.20% during the forecast period Thorough and transparent research studies conducted by a...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Genomic Medicine Market Size and Revenue Forecast to 2032According to the latest report published by Data Bridge Market Research, the Genomic Medicine Market Global genomic medicine market size was valued at USD 36.03 billion in 2024 and is projected to reach USD 118.11 billion by 2032, with a CAGR of 16.00% during the forecast period of 2025 to 2032. DBMR team is focused on understanding client’s business and their needs so...0 Commentaires 0 Parts 51 Vue 0 Aperçu
-
Global Multi-target MET TKIs Market Growing at 7.6% CAGR Through 2034According to a new report from Intel Market Research, the global Multi-target MET TKIs market was valued at USD 1.52 billion in 2025 and is projected to reach USD 3.18 billion by 2034, growing at a CAGR of 7.6% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of non-small cell lung cancer and medullary thyroid cancer, precision oncology...0 Commentaires 0 Parts 471 Vue 0 Aperçu
-
Lipoprotein(a)-Targeted RNA Therapeutics Market Size and Revenue Forecast to 2033According to the latest report published by Data Bridge Market Research, the Lipoprotein(a)-Targeted RNA Therapeutics Market The Lipoprotein(a)-Targeted RNA Therapeutics Market was valued at USD 1.68 billion in 2025 and is projected to reach USD 7.17 billion by 2033, growing at a CAGR of 19.90% from 2026 to 2033. The market is witnessing strong growth driven by...0 Commentaires 0 Parts 74 Vue 0 Aperçu
-
Noonan Syndrome Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032According to the latest report published by Data Bridge Market Research, the Noonan Syndrome Market The global Noonan syndrome market size was valued at USD 861.98 million in 2024 and is expected to reach USD 1,823.69 million by 2032, at a CAGR of 9.82% during the forecast period Noonan Syndrome Market report offers a thorough overview of product...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
United States ADC for Solid Tumors Market Growing at 8.9% CAGR Through 2034The United States Antibody‑Drug Conjugate (ADC) for Solid Tumors market size was valued at approximately USD 0.55 billion in 2025. The market is projected to grow from approximately USD 0.58 billion in 2026 to around USD 1.04 billion by 2034, exhibiting a CAGR of about 8.9% during the forecast period. Antibody‑Drug Conjugates are targeted therapeutics that combine a monoclonal antibody that...0 Commentaires 0 Parts 182 Vue 0 Aperçu
Plus de résultats
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek